FDA Inspection 729706 — Brio Pharmaceuticals Inc

Brio Pharmaceuticals Inc — FEI 1628196

The FDA completed an inspection of Brio Pharmaceuticals Inc on May 11, 2011 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 11, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Postmarket Surv. and Epidemiology
Location
Houston, TX (United States)